[go: up one dir, main page]

WO2009115944A1 - Method and system for automatically controlling a physiological variable of a patient in a closed loop - Google Patents

Method and system for automatically controlling a physiological variable of a patient in a closed loop Download PDF

Info

Publication number
WO2009115944A1
WO2009115944A1 PCT/IB2009/051011 IB2009051011W WO2009115944A1 WO 2009115944 A1 WO2009115944 A1 WO 2009115944A1 IB 2009051011 W IB2009051011 W IB 2009051011W WO 2009115944 A1 WO2009115944 A1 WO 2009115944A1
Authority
WO
WIPO (PCT)
Prior art keywords
patient
user
physiological variable
additional information
controlling
Prior art date
Application number
PCT/IB2009/051011
Other languages
French (fr)
Inventor
Gerhard Tivig
Rolf Neumann
Guenter Gegner
Harald Greiner
Original Assignee
Philips Intellectual Property & Standards Gmbh
Koninklijke Philips Electronics N.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Philips Intellectual Property & Standards Gmbh, Koninklijke Philips Electronics N.V. filed Critical Philips Intellectual Property & Standards Gmbh
Publication of WO2009115944A1 publication Critical patent/WO2009115944A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/08Measuring devices for evaluating the respiratory organs
    • A61B5/083Measuring rate of metabolism by using breath test, e.g. measuring rate of oxygen consumption
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/145Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/41Detecting, measuring or recording for evaluating the immune or lymphatic systems
    • A61B5/412Detecting or monitoring sepsis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/48Other medical applications
    • A61B5/4836Diagnosis combined with treatment in closed-loop systems or methods
    • A61B5/4839Diagnosis combined with treatment in closed-loop systems or methods combined with drug delivery
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00Devices for influencing the respiratory system of patients by gas treatment, e.g. ventilators; Tracheal tubes
    • A61M16/10Preparation of respiratory gases or vapours
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00Devices for influencing the respiratory system of patients by gas treatment, e.g. ventilators; Tracheal tubes
    • A61M16/10Preparation of respiratory gases or vapours
    • A61M16/12Preparation of respiratory gases or vapours by mixing different gases
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/168Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body
    • A61M5/172Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic
    • A61M5/1723Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic using feedback of body parameters, e.g. blood-sugar, pressure
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H70/00ICT specially adapted for the handling or processing of medical references
    • G16H70/20ICT specially adapted for the handling or processing of medical references relating to practices or guidelines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00Devices for influencing the respiratory system of patients by gas treatment, e.g. ventilators; Tracheal tubes
    • A61M16/0051Devices for influencing the respiratory system of patients by gas treatment, e.g. ventilators; Tracheal tubes with alarm devices
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00Devices for influencing the respiratory system of patients by gas treatment, e.g. ventilators; Tracheal tubes
    • A61M16/021Devices for influencing the respiratory system of patients by gas treatment, e.g. ventilators; Tracheal tubes operated by electrical means
    • A61M16/022Control means therefor
    • A61M16/024Control means therefor including calculation means, e.g. using a processor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/142Pressure infusion, e.g. using pumps
    • A61M2005/14208Pressure infusion, e.g. using pumps with a programmable infusion control system, characterised by the infusion program
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00Special media to be introduced, removed or treated
    • A61M2202/02Gases
    • A61M2202/0208Oxygen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00General characteristics of the apparatus
    • A61M2205/18General characteristics of the apparatus with alarm
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00General characteristics of the apparatus
    • A61M2205/50General characteristics of the apparatus with microprocessors or computers
    • A61M2205/502User interfaces, e.g. screens or keyboards
    • A61M2205/505Touch-screens; Virtual keyboard or keypads; Virtual buttons; Soft keys; Mouse touches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00General characteristics of the apparatus
    • A61M2205/50General characteristics of the apparatus with microprocessors or computers
    • A61M2205/52General characteristics of the apparatus with microprocessors or computers with memories providing a history of measured variating parameters of apparatus or patient
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2230/00Measuring parameters of the user
    • A61M2230/04Heartbeat characteristics, e.g. ECG, blood pressure modulation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2230/00Measuring parameters of the user
    • A61M2230/20Blood composition characteristics
    • A61M2230/205Blood composition characteristics partial oxygen pressure (P-O2)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2230/00Measuring parameters of the user
    • A61M2230/20Blood composition characteristics
    • A61M2230/208Blood composition characteristics pH-value
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/30ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to physical therapies or activities, e.g. physiotherapy, acupressure or exercising
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/20ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems

Definitions

  • the invention relates to the field of automatically controlling a physiological variable of a patient, especially in a closed loop system.
  • a method for automatically controlling a physiological variable of a patient in a closed loop system comprising the following steps: automatically measuring a value for the physiological variable of the patient, and automatically treating the patient in order to affect the physiological variable based on a control algorithm using the measured value of the physiological variable, wherein input of additional information by a user is automatically requested, and wherein the additional information is used in the control algorithm for controlling the actuator.
  • physiological variable refers to a specific variable describing the patient's condition with respect to a specific physiological state, i.e. the patient's blood hemoglobin saturation
  • value or value for the physiological variable refers to a specific measure or indicator which is characteristic for the "physiological variable” and, thus, can also be an indirect measure, i.e. the varying part of the absorption spectrum of a pulse oximeter measurement in case of blood hemoglobin saturation.
  • the controlling procedure is continuously documented in a log file.
  • a log file can in general be at least partly done by paper.
  • the log file is exclusively electronic.
  • the log file preferably comprises at least one of: user inputs, measured values, and occurrence of predefined conditions.
  • the log file is preferably not only accessible after the treatment but already during the controlling procedure.
  • the additional information which is requested to be input by the user comprises at least one of: a currently not available measurement value, a non-measureable value, and a treatment confirmation. This way, the control algorithm can be provided with such additional information which is hardly accessible via automatic measurements and which can highly enhance the automatic controlling process.
  • input of additional information by a user is automatically requested periodically.
  • a protocol engine is run on a patient monitoring platform that allows clinicians to run clinical protocols that can monitor developments in the patient's condition. This application notifies the clinicians when certain conditions or combinations of conditions occur and it documents developments in a log which can be stored for further inspections.
  • a protocol engine is incorporated into a patient monitor allowing clinicians to run multiple clinical protocols simultaneously.
  • all protocol specifics are collected into configuration settings files. It is further, preferred that these settings are localized and therefore are language and country specific.
  • the settings information e.g. all kind of definitions of states and their transitions, parameter and thresholds, advisories and prompts, timing, configuration switches, can be loaded into the monitor.
  • This architecture allows to react on protocol definitions changes being able to perform protocol updates in an easy way without updating software to new versions.
  • protocol updates are carried out in the field by a customer support organization.
  • This architecture further allows for implementing different control loop levels, e.g. closed loop, supervised closed loop or open loop, or protocol variations of such a closed loop system to adapt to the current situation of the patient and the data currently available.
  • a closed loop system for automatically controlling a physiological variable of a patient, with a measuring unit for measuring a value for the physiological variable of the patient, an actuator for treating the patient in order to affect the physiological variable, a controller which is fed with the value for the physiological variable of the patient and for controlling the actuator based on a control algorithm using the measured value of the physiological variable, a protocol engine device running at least one protocol and for notifying a user and a user interface for indicating user notifications and for manually inputting additional information, wherein the protocol engine device is adapted for automatically requesting input of additional information via the user interface, the additional information being used in the control algorithm for controlling the actuator.
  • Preferred embodiments of the closed loop system according to the invention result from the preferred embodiments of the method according to the invention as described above.
  • the protocol engine device is adapted for documenting the controlling procedure in a log file. Further, it is especially preferred that multiple measuring units are provided. Furthermore, according to a preferred embodiment of the invention, the user interface is adapted for visualizing information on the patient's conditions. Finally, it is preferred the user interface is adapted for indicating an alarm.
  • the invention is the realization of a closed loop controller using a protocol based implementation with preferably one or more of the following features:
  • Natural way to guide the user through the various steps of the treatment by providing an interactive way to incorporate user inputs, e.g. by manually entries for measurements that are currently not available, confirmations, additional inputs for values that cannot be measured.
  • the human interface for the care giver is enhanced by providing multiple outputs that are optimized for the current situation, e.g. alarms, reminders, advisories, therapeutic recommendations or changes in the visualization of relevant data. Based on the current situation of the patient and the data currently available, the user can choose from a list of protocol variations.
  • Protocol definition files and/or configuration files can be used instead of providing different software engines.
  • An electronic log keeps track of all user inputs, all manually entered data and of all transitions to specific states.
  • This protocol log can be reviewed during the patient treatment, can be printed for documentation purpose and is useful for audit trails on compliance to guidelines.
  • the log can be exported to a central monitoring unit for further compliance tracking.
  • control loops e.g. closed loop controls, supervised controls and open loop controls.
  • FiO2 control infusion pumps medication control, e.g. to control the blood pressure of a patient
  • control for depth of anaesthesia e.g. control of intravenous - aesthetic agents during non-volatile anaesthesia procedures
  • glycemic control e.g. control of intravenous - aesthetic agents during non-volatile anaesthesia procedures
  • This method and system will be used mainly for hospitalized patients, but there are also applications possible for mobile patients in the hospital environment, during transport or at home. Also devices could make use of this invention that are intended for healthy persons or even animals.
  • Fig. 1 schematically depicts a system for a closed loop control according to a preferred embodiment of the invention
  • Fig. 2 schematically depicts a system for a closed loop control according to another preferred embodiment of the invention.
  • Fig. 3 schematically depicts a system for monitoring and controlling a patient according to still another preferred embodiment of the invention.
  • an optimized implementation approach of a physiologic closed-loop controller using a protocol engine as illustrated in Fig. 1 is provided.
  • a further preferred embodiment is the implementation of a closed loop controller using a protocol engine inside a patient monitor as shown in Fig. 2.
  • the closed loop system for automatically controlling a physiological variable of a patient 1 comprises a measuring unit 2 for measuring a value of the physiological variable of the patient 1, an actuator 3 for treating the patient in order to affect the physiological variable, and a controller 4 which is fed with the value for the physiological variable of the patient and for controlling the actuator 3 based on a control algorithm using the measured value of the physiological variable.
  • a protocol engine device 5 is provided which is running at least one protocol and which is further adapted for notifying a user. For such user notifications and for manually inputting additional information, a user interface 6 is provided.
  • controller 4, protocol engine device 5, and user interface 6 are implemented in a patient monitor 7 according to a further preferred embodiment of the invention.
  • the protocol engine device 5 is adapted for automatically requesting input of additional information via the user interface 6.
  • This additional information is used in the control algorithm for controlling the actuator 3 as set out in detail in the following.
  • the protocol engine device is incorporated in patient monitor which allows clinicians to run multiple clinical protocols simultaneously. All protocol specifics are collected in configuration settings files. These settings are localized and therefore language and country specific.
  • the settings information i.e. all kind of definitions of states and their transitions, parameters and thresholds, advisories and prompts, timing, configuration switches are loaded into the patient monitor 7.
  • different control loop levels e.g. closed loop, supervised closed loop or open loop, or protocol variations of such a closed loop system to adapt to the current situation of the patient and the data currently available can be achieved.
  • the protocol engine device 5, and the user interface 6 into patient monitor 7 is defined as a device/system that combines a protocol engine with at least the following functions:
  • Measure at least one physiological signal Measure at least one physiological signal, and Alarming capabilities for at least one measured signal and/or at least one interfaced physiological signal.
  • a patient monitor may comprise one or more of the following features:
  • a wired or wireless connected medical system solution e.g. a central station, a hospital information system, an electronic medical record.
  • Such a system allows reacting on multiple inputs and producing multiple outputs.
  • the protocol summarizes all decision nodes, actions, rules and states: Decision nodes: Evaluate logical combinations of input variables.
  • Actions Execute a specific action, e.g. change the screen.
  • Rules Connect the nodes with the actions.
  • any parameter combination e.g. one or more SpO2 measurements, transcutaneous measurement, skin color, blood gases, etc. can be combined to act as input variables for decision node interpretation.
  • the list of output actions includes the issuing of alerts, reminders and advisories, or switching to an application specific screen containing application specific graphical presentations like horizon trends, histogram view, events review or starting some application specific timers. Escalating notification levels can be implemented using graded severity alerts and advisories. Thus, this way, executing a clinical protocol in the patient monitor is allowed. It is an advantage of the preferred embodiment of the invention described above that the user can select from a list of several possible protocols, e.g.
  • closed loop control sepsis, ventilation weaning or ARDS (acute respiratory distress syndrome support, etc.) those which shall run simultaneously in the monitor.
  • ARDS acute respiratory distress syndrome support, etc.
  • all user interactions as well as user notifications are integrated into the overall patient monitor user interface. The user does not have to deal with an additional device for closed loop control.
  • the protocol engine based closed loop controller acts "behind the scene".
  • a further advantage of the integrated protocol engine is the capability to visualize for orientation purposes in which phase a specific protocol is and to inform the user whether the protocol is currently active or not on the same patient centric user interface.
  • a system for monitoring and controlling a patient 1 which comprises a patient sensor 2 for capturing a patient signal.
  • the system further comprises a patient monitor 7 with an integrated closed loop controller 14 which is fed with the patient signal and which controls a patient treating device 15, in the present case a mechanical ventilator, for treating the patient 1, i.e. for providing the patient 1 with oxygen.
  • a user interface 6 is provided.
  • This user interface 6 is adapted indicating information, e.g. information on the patient 1, on a display 17.
  • the user interface 6 comprises an input device 18, like a keyboard or a touch screen which can be identical with the display 17, which allows a user to input data. Requests for such data input by the user can be indicated via the display 17.
  • a monitoring processer 19 for processing the patient signal and for outputting processed data to the user interface 6, and a control processer 20 for processing the patient signal and for outputting processed data to the closed loop controller 14, are provided.
  • the monitoring processer 19 and the control processer 20 are fed with the same patient signal in the same pre-processing state.
  • the system also comprises an alarming unit 21 which is fed with the patient signal and which is adapted for providing common alarm conditions for monitoring and controlling, e.g. via display 17.
  • FiO2 is controlled automatically, i.e. closed loop control is performed.
  • the display 17 is only used for indicating monitoring data and no external data input is requested. Due to intentionally induced changes in the FiO2 value and/or due to changes of the FiO2 value due to normal control activities, according changes in the captured SpO2 value are expected.
  • This feedback is continuously kept under surveillance, and based on this feedback, there are the following actions of the system:
  • the response does not match with the current model of the transfer functions, but the deviations are in a range that allows to automatically adjusting the model of the transfer functions accordingly.
  • the user might get a low priority warning in regards to the model changes so the user can verify what triggered the changes of the transfer function and might want to correct those.
  • the 02 uptake of the lung is reduced due to accumulation of secretion, but with a slightly increase FiO2 level this can be compensated.
  • the care giver could improve the situation by sucking the patient airways this would trigger a medium or low urgency notification to the user.
  • the response does not match with the current model of the transfer functions and the deviations are so extreme or do not fit into the model that an automatically adjustment of the model is not feasible or too risky.
  • the user is informed of this situation with a higher urgency.
  • the urgency level might also depend on the actual state of the patient variable, but in any case it is important the user is aware of the situation as it might be impossible for the closed loop system to properly react on potential degradation of the patient's conditions in the future. For example, due to airway obstruction there is nearly no air reaching the lungs so the SaO2 will drop quickly even when the FiO2 is set to the maximum. This is a change in the transfer function of the patient that cannot be compensated by the closed loop control system.
  • a high urgency notification is triggered to the user.
  • the 02 supply for the patient got disconnected and the patient is breathing room air.
  • this might cause only a slight drop of SaO2 that might still be in the acceptable range, but the closed loop controller has no control anymore to provide higher FiO2 levels if the patient might require it in the future.
  • This triggers a medium urgency notification to the user.
  • a change from closed loop to open loop is performed and input of external data from a user is requested.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medical Informatics (AREA)
  • Physics & Mathematics (AREA)
  • Surgery (AREA)
  • Molecular Biology (AREA)
  • Pathology (AREA)
  • Biophysics (AREA)
  • Emergency Medicine (AREA)
  • Pulmonology (AREA)
  • Anesthesiology (AREA)
  • Hematology (AREA)
  • Physiology (AREA)
  • Obesity (AREA)
  • Primary Health Care (AREA)
  • Epidemiology (AREA)
  • Bioethics (AREA)
  • Vascular Medicine (AREA)
  • Optics & Photonics (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)

Abstract

The invention relates to a closed loop system for automatically controlling a physiological variable of a patient(1), with a measuring unit(2)for measuring a value for the physiological variable of the patient(1), an actuator(3)for treating the patient (1)in order to affect the physiological variable, a controller (4)which is fed with the value for the physiological variable of the patient(1)and for controlling the actuator (3) based on a control algorithm using the measured value of the physiological variable, a protocol engine device(5)running at least one protocol and for notifying a user and a user interface (6)for indicating user notifications and for manually inputting additional information, wherein the protocol engine device(5)is adapted for automatically requesting input of additional information via the user interface(6), the additional information being used in the control algorithm for controlling the actuator(3). Accordingly, such a system for automatically controlling a physiological variable of a patient (1)in a closed loop is provided which is reliable, easy to handle, and especially highly accepted by the care givers.

Description

METHOD AND SYSTEM FOR AUTOMATICALLY CONTROLLING A PHYSIOLOGICAL VARIABLE OF A PATIENT IN A CLOSED LOOP
FIELD OF THE INVENTION
The invention relates to the field of automatically controlling a physiological variable of a patient, especially in a closed loop system. BACKGROUND OF THE INVENTION
The idea of a closed loop controller in clinical systems has been known for more than a decade. For research purposes, closed loop systems have been studied, but as of today, there is no generally accepted clinical use of such systems.
The main reason for this limited use is the large step from a manually controlled therapy to an automatic closed loop system. Applying such a large step to the care of patients generates ethical concerns and also very high regulatory hurdles. Moreover, the acceptance was limited due to missing transparency. With the available approaches of closed implementations, the system could be very simple but inflexible in its application or with an overwhelming, complex human interface.
Classic controller implementations have several disadvantages as reduced flexibility, difficulty to adapt to new requirements in terms of new measurements, different thresholds, modified timing and/or user interface, difficulty to upgrade functionality when new protocol requirements come out etc.
SUMMARY OF THE INVENTION It is the object of the invention to provide such a method and system for automatically controlling a physiological variable of a patient in a closed loop which are reliable, easy to handle, and especially highly accepted by the care givers.
This object is achieved by a method for automatically controlling a physiological variable of a patient in a closed loop system, comprising the following steps: automatically measuring a value for the physiological variable of the patient, and automatically treating the patient in order to affect the physiological variable based on a control algorithm using the measured value of the physiological variable, wherein input of additional information by a user is automatically requested, and wherein the additional information is used in the control algorithm for controlling the actuator. Accordingly, it is an essential feature of the invention to provide such a method for controlling the physiological variable which is flexible and which can be adapted to the needs of the patient during treatment since input of additional information by the user is requested automatically. Especially, using this method to implement a closed loop controller provides the following advantages: A natural way to guide the user through the various steps of the treatment is offered since an interactive way to incorporate user inputs is provided. By involving the user actively into the control mechanism the acceptance level to implement a closed loop system in the daily clinical use is highly increased. This way, increased flexibility to represent different phases of treatment is provided. It is to be noted that in this context, the term "patient" does not only apply to human beings but also to animals. Further, the term "patient" does not mean that the respective person/animal is disease-ridden and, thus, also healthy persons who make part of a medical system which is controlled by a closed loop will be referred to as "patients". Further, the term "physiological variable" refers to a specific variable describing the patient's condition with respect to a specific physiological state, i.e. the patient's blood hemoglobin saturation, while the term "value" or "value for the physiological variable" refers to a specific measure or indicator which is characteristic for the "physiological variable" and, thus, can also be an indirect measure, i.e. the varying part of the absorption spectrum of a pulse oximeter measurement in case of blood hemoglobin saturation.
In general it might be sufficient that only one value for one physiological variable is measured. However, according to a preferred embodiment of the invention, multiple values for one or more physiological variables are measured.
Further, according to a preferred embodiment of the invention, the controlling procedure is continuously documented in a log file. Such a log file can in general be at least partly done by paper. However, it is preferred, that the log file is exclusively electronic. Further, the log file preferably comprises at least one of: user inputs, measured values, and occurrence of predefined conditions. Furthermore, the log file is preferably not only accessible after the treatment but already during the controlling procedure. According to a preferred embodiment of the invention, the additional information which is requested to be input by the user comprises at least one of: a currently not available measurement value, a non-measureable value, and a treatment confirmation. This way, the control algorithm can be provided with such additional information which is hardly accessible via automatic measurements and which can highly enhance the automatic controlling process. Further, according to a preferred embodiment of the invention, input of additional information by a user is automatically requested periodically.
Moreover, according to a preferred embodiment of the invention, input of additional information by a user is automatically requested upon occurrence of a condition which is predefined in a protocol. With respect to this, a protocol engine is run on a patient monitoring platform that allows clinicians to run clinical protocols that can monitor developments in the patient's condition. This application notifies the clinicians when certain conditions or combinations of conditions occur and it documents developments in a log which can be stored for further inspections. In other words, according to this preferred embodiment of the invention, a protocol engine is incorporated into a patient monitor allowing clinicians to run multiple clinical protocols simultaneously. Preferably, all protocol specifics are collected into configuration settings files. It is further, preferred that these settings are localized and therefore are language and country specific. The settings information, e.g. all kind of definitions of states and their transitions, parameter and thresholds, advisories and prompts, timing, configuration switches, can be loaded into the monitor.
This architecture allows to react on protocol definitions changes being able to perform protocol updates in an easy way without updating software to new versions. Preferably, protocol updates are carried out in the field by a customer support organization. This architecture further allows for implementing different control loop levels, e.g. closed loop, supervised closed loop or open loop, or protocol variations of such a closed loop system to adapt to the current situation of the patient and the data currently available.
Above mentioned object is further addressed by a closed loop system for automatically controlling a physiological variable of a patient, with a measuring unit for measuring a value for the physiological variable of the patient, an actuator for treating the patient in order to affect the physiological variable, a controller which is fed with the value for the physiological variable of the patient and for controlling the actuator based on a control algorithm using the measured value of the physiological variable, a protocol engine device running at least one protocol and for notifying a user and a user interface for indicating user notifications and for manually inputting additional information, wherein the protocol engine device is adapted for automatically requesting input of additional information via the user interface, the additional information being used in the control algorithm for controlling the actuator. Preferred embodiments of the closed loop system according to the invention result from the preferred embodiments of the method according to the invention as described above.
Especially, according to a preferred embodiment of the invention, the protocol engine device is adapted for documenting the controlling procedure in a log file. Further, it is especially preferred that multiple measuring units are provided. Furthermore, according to a preferred embodiment of the invention, the user interface is adapted for visualizing information on the patient's conditions. Finally, it is preferred the user interface is adapted for indicating an alarm.
As a result, the invention is the realization of a closed loop controller using a protocol based implementation with preferably one or more of the following features:
Natural way to guide the user through the various steps of the treatment, by providing an interactive way to incorporate user inputs, e.g. by manually entries for measurements that are currently not available, confirmations, additional inputs for values that cannot be measured.
By involving the user actively into the control mechanism the acceptance level to implement a closed loop system in the daily clinical use is increased.
User inputs are only requested when necessary, but user can be reminded periodically to provide input.
Increased flexibility to represent different phases of treatment. Improved performance and adaptability to new clinical requirements by the capability to react on multiple inputs.
The human interface for the care giver is enhanced by providing multiple outputs that are optimized for the current situation, e.g. alarms, reminders, advisories, therapeutic recommendations or changes in the visualization of relevant data. Based on the current situation of the patient and the data currently available, the user can choose from a list of protocol variations.
Protocol definition files and/or configuration files can be used instead of providing different software engines.
An electronic log keeps track of all user inputs, all manually entered data and of all transitions to specific states. This protocol log can be reviewed during the patient treatment, can be printed for documentation purpose and is useful for audit trails on compliance to guidelines. The log can be exported to a central monitoring unit for further compliance tracking.
One of ordinary skill in the art will recognize that the purpose of controlling is not limited to a single type of control loop and includes several variations and different implementations of control loops, e.g. closed loop controls, supervised controls and open loop controls. Examples are: FiO2 control, infusion pumps medication control, e.g. to control the blood pressure of a patient, control for depth of anaesthesia, e.g. control of intravenous - aesthetic agents during non-volatile anaesthesia procedures, and glycemic control. One of ordinary skill in the art will appreciate many variations and modifications within the scope of this invention. This method and system will be used mainly for hospitalized patients, but there are also applications possible for mobile patients in the hospital environment, during transport or at home. Also devices could make use of this invention that are intended for healthy persons or even animals. BRIEF DESCRIPTION OF THE DRAWINGS
These and other aspects of the invention will be apparent from and elucidated with reference to the embodiments described hereinafter.
In the drawings:
Fig. 1 schematically depicts a system for a closed loop control according to a preferred embodiment of the invention,
Fig. 2 schematically depicts a system for a closed loop control according to another preferred embodiment of the invention, and
Fig. 3 schematically depicts a system for monitoring and controlling a patient according to still another preferred embodiment of the invention.
DETAILED DESCRIPTION OF EMBODIMENTS
According to a preferred embodiment of the invention, an optimized implementation approach of a physiologic closed-loop controller using a protocol engine as illustrated in Fig. 1 is provided. A further preferred embodiment is the implementation of a closed loop controller using a protocol engine inside a patient monitor as shown in Fig. 2.
As can be seen from Fig. 1, the closed loop system for automatically controlling a physiological variable of a patient 1 according to a preferred embodiment of the invention comprises a measuring unit 2 for measuring a value of the physiological variable of the patient 1, an actuator 3 for treating the patient in order to affect the physiological variable, and a controller 4 which is fed with the value for the physiological variable of the patient and for controlling the actuator 3 based on a control algorithm using the measured value of the physiological variable. Further, a protocol engine device 5 is provided which is running at least one protocol and which is further adapted for notifying a user. For such user notifications and for manually inputting additional information, a user interface 6 is provided.
As can be seen from Fig. 2, controller 4, protocol engine device 5, and user interface 6 are implemented in a patient monitor 7 according to a further preferred embodiment of the invention. In these closed loop systems the protocol engine device 5 is adapted for automatically requesting input of additional information via the user interface 6. This additional information is used in the control algorithm for controlling the actuator 3 as set out in detail in the following. As shown in Fig. 2, the protocol engine device is incorporated in patient monitor which allows clinicians to run multiple clinical protocols simultaneously. All protocol specifics are collected in configuration settings files. These settings are localized and therefore language and country specific. The settings information, i.e. all kind of definitions of states and their transitions, parameters and thresholds, advisories and prompts, timing, configuration switches are loaded into the patient monitor 7. This way, different control loop levels, e.g. closed loop, supervised closed loop or open loop, or protocol variations of such a closed loop system to adapt to the current situation of the patient and the data currently available can be achieved.
With respect to the implementation of controller 4, the protocol engine device 5, and the user interface 6 into patient monitor 7, the term "patient monitor" is defined as a device/system that combines a protocol engine with at least the following functions:
Measure at least one physiological signal, and Alarming capabilities for at least one measured signal and/or at least one interfaced physiological signal.
Further, a patient monitor may comprise one or more of the following features:
At least one external signal to control external, preferably medical, equipment. - User interface possibilities to visualize measured and interfaced physiological signals.
Trending possibilities for measured and interfaced physiological signals.
Possibilities to analyze actual and trended measured and interfaced physiological signals as done with clinical decision support systems: e.g. events, other protocol engines. - Possibilities to interact with the user and let the user enter data and comments of physiological and non physiological data, i.e. by manual entry.
Infrastructure to transfer captured and processed data to a wired or wireless connected medical system solution, e.g. a central station, a hospital information system, an electronic medical record.
Such a system allows reacting on multiple inputs and producing multiple outputs. A wide variety of input conditions is accepted: These can be either continuously monitored vital signs like SpO2, pulse, etc. Further, manual measurements like blood gas data, e.g. pH and PO2, user asked simple questions, like "Type of ventilation used?" or other monitor information like skin colour or patient category can be used. All these data can be combined using logic to information nodes which are parsed by the protocol engine to decide upon appropriate output actions. The base of all decisions is given by decision nodes. Input variables are connected by logical combinations, e.g. "If SpO2 available and Patient Category = Neonatal", and form decision nodes. Based on the evaluation of decision nodes actions can be executed. Actions are connected to decision nodes by rules.
The protocol summarizes all decision nodes, actions, rules and states: Decision nodes: Evaluate logical combinations of input variables.
Actions: Execute a specific action, e.g. change the screen. Rules: Connect the nodes with the actions.
States: Activate the appropriate rules.
One state is active at one point in time. Each state might have specific, specialized rules. For example: "If SpO2 available and patient category = neonatal" a state transition to the "acquiring" state follows. This "acquiring" state then is the starting point where all pertinent questions regarding the patient and any specific patient condition are inquired from the user. After this state is completed, i.e. the minimum required information is available, the protocol engine transfers to the "control" state in which the closed loop is applied. Based on specific pre-defined or user-defined conditions the protocol engine transfers to specific other states, e.g. a "wait" state during specific patient related procedures like suctioning or feeding.
Generally, any parameter combination, e.g. one or more SpO2 measurements, transcutaneous measurement, skin color, blood gases, etc. can be combined to act as input variables for decision node interpretation. The list of output actions includes the issuing of alerts, reminders and advisories, or switching to an application specific screen containing application specific graphical presentations like horizon trends, histogram view, events review or starting some application specific timers. Escalating notification levels can be implemented using graded severity alerts and advisories. Thus, this way, executing a clinical protocol in the patient monitor is allowed. It is an advantage of the preferred embodiment of the invention described above that the user can select from a list of several possible protocols, e.g. closed loop control, sepsis, ventilation weaning or ARDS (acute respiratory distress syndrome support, etc.) those which shall run simultaneously in the monitor. It is another advantage that all user interactions as well as user notifications are integrated into the overall patient monitor user interface. The user does not have to deal with an additional device for closed loop control. The protocol engine based closed loop controller acts "behind the scene". A further advantage of the integrated protocol engine is the capability to visualize for orientation purposes in which phase a specific protocol is and to inform the user whether the protocol is currently active or not on the same patient centric user interface.
For further elucidation of the principles of the invention, referring to Fig. 3, in the following a system is described as another preferred embodiment of the invention, wherein the SaO2 value of a patient is controlled by adjusting the FiO2 concentration of the gas mixture that is provided to the patient. For example, this can be implemented in a closed loop control of blood oxygen saturation in premature infants. As depicted in the Fig. 3, according to the preferred embodiment of the invention, a system for monitoring and controlling a patient 1 , is provided which comprises a patient sensor 2 for capturing a patient signal. The system further comprises a patient monitor 7 with an integrated closed loop controller 14 which is fed with the patient signal and which controls a patient treating device 15, in the present case a mechanical ventilator, for treating the patient 1, i.e. for providing the patient 1 with oxygen.
Further, a user interface 6 is provided. This user interface 6 is adapted indicating information, e.g. information on the patient 1, on a display 17. Furthermore, the user interface 6 comprises an input device 18, like a keyboard or a touch screen which can be identical with the display 17, which allows a user to input data. Requests for such data input by the user can be indicated via the display 17.
Furthermore, a monitoring processer 19 for processing the patient signal and for outputting processed data to the user interface 6, and a control processer 20 for processing the patient signal and for outputting processed data to the closed loop controller 14, are provided. As can be seen from Fig. 3, the monitoring processer 19 and the control processer 20 are fed with the same patient signal in the same pre-processing state. The system also comprises an alarming unit 21 which is fed with the patient signal and which is adapted for providing common alarm conditions for monitoring and controlling, e.g. via display 17.
In the closed loop case, i.e. under normal conditions, FiO2 is controlled automatically, i.e. closed loop control is performed. This means that control is exclusively performed by the closed loop controller 14. The display 17 is only used for indicating monitoring data and no external data input is requested. Due to intentionally induced changes in the FiO2 value and/or due to changes of the FiO2 value due to normal control activities, according changes in the captured SpO2 value are expected. This feedback is continuously kept under surveillance, and based on this feedback, there are the following actions of the system:
1. The current model of the transfer functions is confirmed within acceptable limits and, thus, no adjustments of the model are necessary.
2. The response does not match with the current model of the transfer functions, but the deviations are in a range that allows to automatically adjusting the model of the transfer functions accordingly. Optionally the user might get a low priority warning in regards to the model changes so the user can verify what triggered the changes of the transfer function and might want to correct those. For example, the 02 uptake of the lung is reduced due to accumulation of secretion, but with a slightly increase FiO2 level this can be compensated. As the care giver could improve the situation by sucking the patient airways this would trigger a medium or low urgency notification to the user.
3. The response does not match with the current model of the transfer functions and the deviations are so extreme or do not fit into the model that an automatically adjustment of the model is not feasible or too risky. In this case the user is informed of this situation with a higher urgency. The urgency level might also depend on the actual state of the patient variable, but in any case it is important the user is aware of the situation as it might be impossible for the closed loop system to properly react on potential degradation of the patient's conditions in the future. For example, due to airway obstruction there is nearly no air reaching the lungs so the SaO2 will drop quickly even when the FiO2 is set to the maximum. This is a change in the transfer function of the patient that cannot be compensated by the closed loop control system.
Accordingly, a high urgency notification is triggered to the user. According to another example, the 02 supply for the patient got disconnected and the patient is breathing room air. Depending on the current patients condition this might cause only a slight drop of SaO2 that might still be in the acceptable range, but the closed loop controller has no control anymore to provide higher FiO2 levels if the patient might require it in the future. This triggers a medium urgency notification to the user. However, in all these cases in which the response does not match with the current model of the transfer functions and the deviations are so extreme or do not fit into the model that an automatically adjustment of the model is not feasible or too risky, a change from closed loop to open loop is performed and input of external data from a user is requested. While the invention has been illustrated and described in detail in the drawings and foregoing description, such illustration and description are to be considered illustrative or exemplary and not restrictive; the invention is not limited to the disclosed embodiments.
Other variations to the disclosed embodiments can be understood and effected by those skilled in the art in practicing the claimed invention, from a study of the drawings, the disclosure, and the appended claims. In the claims, the word "comprising" does not exclude other elements or steps, and the indefinite article "a" or "an" does not exclude a plurality. The mere fact that certain measures are recited in mutually different dependent claims does not indicate that a combination of these measured cannot be used to advantage. Any reference signs in the claims should not be construed as limiting the scope.

Claims

CLAIMS:
1. A method for automatically controlling a physiological variable of a patient (1) in a closed loop system, comprising the following steps: automatically measuring a value for the physiological variable of the patient (1), and automatically treating the patient (1) in order to affect the physiological variable based on a control algorithm using the measured value of the physiological variable, wherein input of additional information by a user is automatically requested, and wherein the additional information is used in the control algorithm for controlling the actuator.
2. The method according to claim 1, wherein multiple values for one or more physiological variables are measured.
3. The method according to claim 1 or 2, wherein the controlling procedure is continuously documented in a log file.
4. The method according to claim 3, wherein the log file comprises at least one of: user inputs, measured values, and occurrence of predefined conditions.
5. The method according to claim 3 or 4, wherein the log file is accessible during the controlling procedure.
6. The method according to any of claims 1 to 5, wherein the additional information which is requested to be input by the user comprises at least one of: a currently not available measurement value, a non-measureable value, and a treatment confirmation.
7. The method according to any of claims 1 to 6, wherein input of additional information by a user is automatically requested upon occurrence of a condition which is predefined in a protocol.
8. The method according to any of claims 1 to 7, wherein input of additional information by a user is automatically requested periodically.
9. A closed loop system for automatically controlling a physiological variable of a patient (1), with a measuring unit (2) for measuring a value for the physiological variable of the patient (1), an actuator (3) for treating the patient (1) in order to affect the physiological variable, a controller (4) which is fed with the value for the physiological variable of the patient (1) and for controlling the actuator (3) based on a control algorithm using the measured value of the physiological variable, a protocol engine device (5) running at least one protocol and for notifying a user and a user interface (6) for indicating user notifications and for manually inputting additional information, wherein the protocol engine device (5) is adapted for automatically requesting input of additional information via the user interface (6), the additional information being used in the control algorithm for controlling the actuator (3).
10. The system according to claim 9, wherein the protocol engine device (5) is adapted for documenting the controlling procedure in a log file.
11. The system according to claim 9 or 10, wherein multiple measuring units (2) are provided.
12. The system according to any of claims 9 to 11, wherein the user interface (6) is adapted for visualizing information on the patient's (1) condition.
PCT/IB2009/051011 2008-03-17 2009-03-11 Method and system for automatically controlling a physiological variable of a patient in a closed loop WO2009115944A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP08102664 2008-03-17
EP08102664.3 2008-03-17

Publications (1)

Publication Number Publication Date
WO2009115944A1 true WO2009115944A1 (en) 2009-09-24

Family

ID=40711709

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2009/051011 WO2009115944A1 (en) 2008-03-17 2009-03-11 Method and system for automatically controlling a physiological variable of a patient in a closed loop

Country Status (1)

Country Link
WO (1) WO2009115944A1 (en)

Cited By (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2295097A1 (en) * 2009-09-09 2011-03-16 Fresenius Medical Care Deutschland GmbH Method and apparatus for evaluating values representing a mass or a concentration of a substance present within the body of a patient
US8136527B2 (en) 2003-08-18 2012-03-20 Breathe Technologies, Inc. Method and device for non-invasive ventilation with nasal interface
US8381729B2 (en) 2003-06-18 2013-02-26 Breathe Technologies, Inc. Methods and devices for minimally invasive respiratory support
US8418694B2 (en) 2003-08-11 2013-04-16 Breathe Technologies, Inc. Systems, methods and apparatus for respiratory support of a patient
US8567399B2 (en) 2007-09-26 2013-10-29 Breathe Technologies, Inc. Methods and devices for providing inspiratory and expiratory flow relief during ventilation therapy
US8677999B2 (en) 2008-08-22 2014-03-25 Breathe Technologies, Inc. Methods and devices for providing mechanical ventilation with an open airway interface
US8770193B2 (en) 2008-04-18 2014-07-08 Breathe Technologies, Inc. Methods and devices for sensing respiration and controlling ventilator functions
US8776793B2 (en) 2008-04-18 2014-07-15 Breathe Technologies, Inc. Methods and devices for sensing respiration and controlling ventilator functions
US8925545B2 (en) 2004-02-04 2015-01-06 Breathe Technologies, Inc. Methods and devices for treating sleep apnea
US8939152B2 (en) 2010-09-30 2015-01-27 Breathe Technologies, Inc. Methods, systems and devices for humidifying a respiratory tract
US8955518B2 (en) 2003-06-18 2015-02-17 Breathe Technologies, Inc. Methods, systems and devices for improving ventilation in a lung area
US8985099B2 (en) 2006-05-18 2015-03-24 Breathe Technologies, Inc. Tracheostoma spacer, tracheotomy method, and device for inserting a tracheostoma spacer
US9132250B2 (en) 2009-09-03 2015-09-15 Breathe Technologies, Inc. Methods, systems and devices for non-invasive ventilation including a non-sealing ventilation interface with an entrainment port and/or pressure feature
US9180270B2 (en) 2009-04-02 2015-11-10 Breathe Technologies, Inc. Methods, systems and devices for non-invasive open ventilation with gas delivery nozzles within an outer tube
US9962512B2 (en) 2009-04-02 2018-05-08 Breathe Technologies, Inc. Methods, systems and devices for non-invasive ventilation including a non-sealing ventilation interface with a free space nozzle feature
US10058668B2 (en) 2007-05-18 2018-08-28 Breathe Technologies, Inc. Methods and devices for sensing respiration and providing ventilation therapy
US10099028B2 (en) 2010-08-16 2018-10-16 Breathe Technologies, Inc. Methods, systems and devices using LOX to provide ventilatory support
US10252020B2 (en) 2008-10-01 2019-04-09 Breathe Technologies, Inc. Ventilator with biofeedback monitoring and control for improving patient activity and health
US10792449B2 (en) 2017-10-03 2020-10-06 Breathe Technologies, Inc. Patient interface with integrated jet pump
US11154672B2 (en) 2009-09-03 2021-10-26 Breathe Technologies, Inc. Methods, systems and devices for non-invasive ventilation including a non-sealing ventilation interface with an entrainment port and/or pressure feature
US12296095B2 (en) 2019-09-10 2025-05-13 Fisher & Paykel Healthcare Limited Methods and systems for controlling oxygen delivery in a flow therapy apparatus

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030050621A1 (en) * 2001-09-07 2003-03-13 Lebel Ronald J. Safety limits for closed-loop infusion pump control
WO2005072792A1 (en) * 2004-01-27 2005-08-11 Aspect Medical Systems, Inc. System for adaptive drug delivery
WO2006075016A1 (en) * 2005-01-17 2006-07-20 Novo Nordisk A/S Fluide delivery device with integrated monitoring of physiological characteristics
US20060266355A1 (en) * 2005-05-24 2006-11-30 Boaz Misholi Apparatus and method for controlling fraction of inspired oxygen
US20070173761A1 (en) * 1999-06-03 2007-07-26 Medtronic Minimed, Inc. Apparatus and method for controlling insulin infusion with state variable feedback

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070173761A1 (en) * 1999-06-03 2007-07-26 Medtronic Minimed, Inc. Apparatus and method for controlling insulin infusion with state variable feedback
US20030050621A1 (en) * 2001-09-07 2003-03-13 Lebel Ronald J. Safety limits for closed-loop infusion pump control
WO2005072792A1 (en) * 2004-01-27 2005-08-11 Aspect Medical Systems, Inc. System for adaptive drug delivery
WO2006075016A1 (en) * 2005-01-17 2006-07-20 Novo Nordisk A/S Fluide delivery device with integrated monitoring of physiological characteristics
US20060266355A1 (en) * 2005-05-24 2006-11-30 Boaz Misholi Apparatus and method for controlling fraction of inspired oxygen

Cited By (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8381729B2 (en) 2003-06-18 2013-02-26 Breathe Technologies, Inc. Methods and devices for minimally invasive respiratory support
US8955518B2 (en) 2003-06-18 2015-02-17 Breathe Technologies, Inc. Methods, systems and devices for improving ventilation in a lung area
US8418694B2 (en) 2003-08-11 2013-04-16 Breathe Technologies, Inc. Systems, methods and apparatus for respiratory support of a patient
US8573219B2 (en) 2003-08-18 2013-11-05 Breathe Technologies, Inc. Method and device for non-invasive ventilation with nasal interface
US8136527B2 (en) 2003-08-18 2012-03-20 Breathe Technologies, Inc. Method and device for non-invasive ventilation with nasal interface
US8925545B2 (en) 2004-02-04 2015-01-06 Breathe Technologies, Inc. Methods and devices for treating sleep apnea
US8985099B2 (en) 2006-05-18 2015-03-24 Breathe Technologies, Inc. Tracheostoma spacer, tracheotomy method, and device for inserting a tracheostoma spacer
US10058668B2 (en) 2007-05-18 2018-08-28 Breathe Technologies, Inc. Methods and devices for sensing respiration and providing ventilation therapy
US8567399B2 (en) 2007-09-26 2013-10-29 Breathe Technologies, Inc. Methods and devices for providing inspiratory and expiratory flow relief during ventilation therapy
US8770193B2 (en) 2008-04-18 2014-07-08 Breathe Technologies, Inc. Methods and devices for sensing respiration and controlling ventilator functions
US8776793B2 (en) 2008-04-18 2014-07-15 Breathe Technologies, Inc. Methods and devices for sensing respiration and controlling ventilator functions
US8677999B2 (en) 2008-08-22 2014-03-25 Breathe Technologies, Inc. Methods and devices for providing mechanical ventilation with an open airway interface
US10252020B2 (en) 2008-10-01 2019-04-09 Breathe Technologies, Inc. Ventilator with biofeedback monitoring and control for improving patient activity and health
US9675774B2 (en) 2009-04-02 2017-06-13 Breathe Technologies, Inc. Methods, systems and devices for non-invasive open ventilation with gas delivery nozzles in free space
US11896766B2 (en) 2009-04-02 2024-02-13 Breathe Technologies, Inc. Methods, systems and devices for non-invasive ventilation with gas delivery nozzles in free space
US12364835B2 (en) 2009-04-02 2025-07-22 Breathe Technologies, Inc. Methods, systems and devices for non-invasive ventilation with gas delivery nozzles in free space
US9180270B2 (en) 2009-04-02 2015-11-10 Breathe Technologies, Inc. Methods, systems and devices for non-invasive open ventilation with gas delivery nozzles within an outer tube
US9227034B2 (en) 2009-04-02 2016-01-05 Beathe Technologies, Inc. Methods, systems and devices for non-invasive open ventilation for treating airway obstructions
US12161807B2 (en) 2009-04-02 2024-12-10 Breathe Technologies, Inc. Methods, systems and devices for non-invasive open ventilation with gas delivery nozzles within nasal pillows
US10695519B2 (en) 2009-04-02 2020-06-30 Breathe Technologies, Inc. Methods, systems and devices for non-invasive open ventilation with gas delivery nozzles within nasal pillows
US11103667B2 (en) 2009-04-02 2021-08-31 Breathe Technologies, Inc. Methods, systems and devices for non-invasive ventilation with gas delivery nozzles in free space
US9962512B2 (en) 2009-04-02 2018-05-08 Breathe Technologies, Inc. Methods, systems and devices for non-invasive ventilation including a non-sealing ventilation interface with a free space nozzle feature
US10046133B2 (en) 2009-04-02 2018-08-14 Breathe Technologies, Inc. Methods, systems and devices for non-invasive open ventilation for providing ventilation support
US10709864B2 (en) 2009-04-02 2020-07-14 Breathe Technologies, Inc. Methods, systems and devices for non-invasive open ventilation with gas delivery nozzles with an outer tube
US11707591B2 (en) 2009-04-02 2023-07-25 Breathe Technologies, Inc. Methods, systems and devices for non-invasive open ventilation with gas delivery nozzles with an outer tube
US10232136B2 (en) 2009-04-02 2019-03-19 Breathe Technologies, Inc. Methods, systems and devices for non-invasive open ventilation for treating airway obstructions
US11154672B2 (en) 2009-09-03 2021-10-26 Breathe Technologies, Inc. Methods, systems and devices for non-invasive ventilation including a non-sealing ventilation interface with an entrainment port and/or pressure feature
US9132250B2 (en) 2009-09-03 2015-09-15 Breathe Technologies, Inc. Methods, systems and devices for non-invasive ventilation including a non-sealing ventilation interface with an entrainment port and/or pressure feature
US12048813B2 (en) 2009-09-03 2024-07-30 Breathe Technologies, Inc. Methods, systems and devices for non-invasive ventilation including a non-sealing ventilation interface with an entrainment port and/or pressure feature
EP2295097A1 (en) * 2009-09-09 2011-03-16 Fresenius Medical Care Deutschland GmbH Method and apparatus for evaluating values representing a mass or a concentration of a substance present within the body of a patient
US10551370B2 (en) 2009-09-09 2020-02-04 Fresenius Medical Care Deutschland Gmbh Method and apparatus for evaluating values representing a mass or a concentration of a substance present within the body of a patient
WO2011029569A1 (en) * 2009-09-09 2011-03-17 Fresenius Medical Care Deutschland Gmbh Method and apparatus for evaluating values representing a mass or a concentration of a substance present within the body of a patient
US9301716B2 (en) 2009-09-09 2016-04-05 Fresenius Medical Care Deutschland Gmbh Method and apparatus for evaluating values representing a mass or a concentration of a substance present within the body of a patient
AU2010294525B2 (en) * 2009-09-09 2015-09-17 Fresenius Medical Care Deutschland Gmbh Method and apparatus for evaluating values representing a mass or a concentration of a substance present within the body of a patient
US10099028B2 (en) 2010-08-16 2018-10-16 Breathe Technologies, Inc. Methods, systems and devices using LOX to provide ventilatory support
US8939152B2 (en) 2010-09-30 2015-01-27 Breathe Technologies, Inc. Methods, systems and devices for humidifying a respiratory tract
US9358358B2 (en) 2010-09-30 2016-06-07 Breathe Technologies, Inc. Methods, systems and devices for humidifying a respiratory tract
US10792449B2 (en) 2017-10-03 2020-10-06 Breathe Technologies, Inc. Patient interface with integrated jet pump
US12017002B2 (en) 2017-10-03 2024-06-25 Breathe Technologies, Inc. Patient interface with integrated jet pump
US12296095B2 (en) 2019-09-10 2025-05-13 Fisher & Paykel Healthcare Limited Methods and systems for controlling oxygen delivery in a flow therapy apparatus

Similar Documents

Publication Publication Date Title
WO2009115944A1 (en) Method and system for automatically controlling a physiological variable of a patient in a closed loop
US8423381B2 (en) Patient monitor with integrated closed loop controller
US20230245755A1 (en) Ventilation management system
US12272457B2 (en) Ventilation system
US11328808B2 (en) Respiratory knowledge portal
US20210290184A1 (en) Remote patient management and monitoring systems and methods
US9700218B2 (en) Systems and methods for reducing nuisance alarms in medical devices
US9101335B2 (en) Method, arrangement and computer program product for managing alarms in patient monitoring
CN110740685B (en) System and method for driving optical sensor
US20120053422A1 (en) Method, Device and Computer Program Product for Monitoring Patients Receiving Care
CN109155157A (en) For providing the method and system for being directed to the customization setting of patient monitor
CN107088242B (en) Automatic anesthesia pump with improved mobility for anesthesiologist
US20200085303A1 (en) Telemonitoring in respiration
EP3667605B1 (en) Ventilation management system
US20200273568A1 (en) Method For Operating At Least One Respirator In A Communication Network
WO2014143152A1 (en) Ventilation management system

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 09721687

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 09721687

Country of ref document: EP

Kind code of ref document: A1